Investors
Latest press release
Latest press release
Continued strong growth – adjusted EBITA increased by 13 percent
MedCap's financial development
MedCap seeks to provide accurate and timely information to the stock market and its stakeholders. The following pages contain financial reports, presentations, press releases and information about the company’s financial performance.
Please also refer to the “About MedCap” section to find out more about our mission, strategy and how we create value.
Press releases
Calendar
-
Interim report 3 2024
-
SEB Healthcare Seminar 2024
-
Nordea Equities Micro Cap Seminar
MedCap as an investment
MedCap acquires and develops profitable, market-leading niche companies in the life science industry in Northern Europe that have the potential to grow internationally. The group conducts operations in three areas: Assistive Tech, MedTech and Specialty Pharma.
Corporate governance
The company complies with Nasdaq Stockholm’s rules for issuers and applies the Swedish Corporate Governance Code (the “Code”).
Contact
-
Anders Dahlberg - CEO +46 704 269 262 anders.dahlberg@medcap.se -
Kristina Ekblad - CFO +46 703 32 21 67 kristina.ekblad@medcap.se